OSOPF yields 2682.25% · PFE yields 6.20%● Live data
📍 OSOPF pulled ahead of the other in Year 1
Combined, OSOPF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OSOPF + PFE for your $10,000?
Osotspa Public Company Limited, together with its subsidiaries manufactures and distributes energy drinks and personal care products worldwide. The company operates in three segments: Beverage, Personal Care, and Others. It offers energy drinks under the M-150, Lipovitan-D, Chalarm, Som in-Sum, White Shark, Shark Energy Drink, and M-Storm brand names; ready-to drink coffee under the M-Presso name; sport drinks under the M-Electrolyte brand; and functional drinks under the Peptein, Peptein Gold, C-Vitt, Calpis Lacto, and Slimma brands. The company also provides baby care products under the Babi Mild brand name; male grooming products under the Exit brand; women beauty care products under the Twelve Plus, Plantstory, Ole Strwaberry, PROhada, and OTG brands; healthcare products under the KRISNAKLAN, Utaitip, Tamjai, YATHAD 4, Yixin, and BANNER brands; and confectionery products under the Botan and Ole brand names. In addition, it provides marketing and property rental services; manufactures and distributes glass, and beverage concentrates and premixes; and distributes food, beverages, and cullet products. Further, the company engages in the import, retail, and wholesale of beverages; investing in other companies; provision of research and development services; electronic commerce business; and education and sale of herbal products. Additionally, it obtains licensing fee for use of trademark, as well as offers manufacturing and distribution services. Osotspa Public Company Limited was founded in 1891 and is based in Bangkok, Thailand.
Full OSOPF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.